Peter Haytaian
EVP and President, Carelon and Carelon Rx
Elevance Health, Inc. · ELV
$7.1M
Reported total · FY2025 · SCT Total as filed
Source: DEF 14A filed March 27, 2026. Prior years are from that filing's three-year table.
Catalog as of September 15, 2026. Not a live market feed.
- Salary
- $950K
- Stock Awards
- $3.8M
- Option Awards
- $1.2M
- Incentives
- $986K
- Other
- $122K
Compensation History
| Fiscal Year | Salary | Stock Awards | Total Compensation |
|---|---|---|---|
| 2025 | $950,000 | $3,840,306 | $7,098,488 |
| 2024 | $950,000 | $3,600,081 | $6,345,127 |
| 2023 | $944,231 | $3,225,051 | $6,978,051 |
Current Position
- Company
- Elevance Health, Inc.
- Title
- EVP and President, Carelon and Carelon Rx
- Ticker
- ELV · NYSE
- Fiscal Year
- 2025
SEC Sources
Fiscal years below are columns from the latest DEF 14A Summary Compensation Table (filed March 27, 2026), not separate historical filings.
| Fiscal Year | Source |
|---|---|
| 2025 | View SEC filing |
| 2024 | View SEC filing |
| 2023 | View SEC filing |
Accession 0001156039-26-000031.
Other Elevance Health Executives
Gail Boudreaux
President And Chief Executive Officer (ceo)
Elevance Health · ELV
$22.6M
FY 2025 · DEF 14A
Mark Kaye
EVP and Chief Financial Officer (CFO)
Elevance Health · ELV
$8M
FY 2025 · DEF 14A
Felicia Norwood
EVP and Chief Health Benefits Officer
Elevance Health · ELV
$7.1M
FY 2025 · DEF 14A
Morgan Kendrick
Evp And President, Commercial And Specialty Health Benefits
Elevance Health · ELV
$6.7M
FY 2025 · DEF 14A